Letter

Letter to FDA on Proposed Rule Regarding Infant Formula


05.22.14

Excerpt: We write to inform you of the significant concerns we share about the process the Food and Drug Administration (FDA) followed in issuing interim final rule (IFR) on February 10, 2014, relating to quality manufacturing standards for infant formula.

To read the letter, click here


Subcommittees
Health (113th Congress)
Letter